ClinicalTrials.Veeva

Menu

Acute Neurochemical and Cognitive Changes After HIIT vs MICT/LICT (ANCCR)

A

Aksaray University Training and Research Hospital

Status

Completed

Conditions

Lactate
Cognitive Performance
Exercise Intensity
BDNF

Treatments

Behavioral: Low Intensity Exercise
Behavioral: Moderate-Intensity Continuous Exercise
Behavioral: High-Intensity Interval Training

Study type

Interventional

Funder types

Other

Identifiers

NCT07379879
185-8/10

Details and patient eligibility

About

This study examines whether the intensity of a single running session changes a blood marker related to brain health (brain-derived neurotrophic factor, BDNF), blood lactate, and performance on a short thinking task that measures attention and self-control (the Stroop test) in healthy young adult men.

Twelve healthy males (18-25 years) will complete four separate sessions in a randomized, counterbalanced order, with at least 7 days between sessions. Each session includes an 8-minute warm-up followed by 24 minutes of one of the following conditions: low-intensity continuous running, moderate-intensity continuous running, high-intensity interval running (repeated 15-second fast runs with 15-second passive rest, organized into sets), or a seated rest control session. Running pace will be individualized based on a prior fitness test.

A small venous blood sample (about 8 mL) will be collected immediately before and within 1 minute after each session. After each session, participants will complete the Stroop test. The main outcomes are the before-to-after changes in serum BDNF, blood lactate, and Stroop test performance across the four conditions.

Enrollment

12 patients

Sex

Male

Ages

18 to 25 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Aged between 18 and 25 years
  • No known medical condition that prevents participation in exercise
  • Not currently using any pharmacological agents

Exclusion criteria

  • Experiencing any discomfort before, during, or after exercise
  • Current or past diagnosis of pharmacological or doping substance use
  • Engaging in regular exercise (more than 3 times per week) within the last 2 weeks
  • History of alcohol or substance addiction
  • Any other condition or factor that may prevent full participation in the study protocol

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

12 participants in 4 patient groups

Control
No Intervention group
Description:
Participants remained seated quietly at rest for 24 minutes in a quiet, well-lit room, matched to the exercise sessions for time schedule and environmental conditions. No physical activity was performed during this period.
Low-intensity continuous training
Experimental group
Description:
They were asked to perform low intensity exercise for the specified time, determined according to their maximal oxygen consumption capacity.
Treatment:
Behavioral: Low Intensity Exercise
Moderate-intensity continuous training
Experimental group
Description:
They were asked to perform moderate intensity exercise for the specified time, determined according to their maximal oxygen consumption capacity.
Treatment:
Behavioral: Moderate-Intensity Continuous Exercise
High-intensity interval training
Experimental group
Description:
They were asked to perform HIIT exercise for the specified time, determined according to their maximal oxygen consumption capacity.
Treatment:
Behavioral: High-Intensity Interval Training

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems